Seeking Alpha

Dr. Paul Nunzio...'s  Instablog

Dr. Paul Nunzio DeSantis, Pharm.D
Send Message
Earned a Doctorate in Pharmacy (Pharm.D.) in 2010 and Pre-Pharmacy/B.S. in Molecular Biology in 2006. Over six years of direct experience in translational research in oncology investigating the molecular/cellular mechanisms of carcinogenesis focused on biomarker identification and validation... More
My company:
Alpha BioPharma Advisers
My blog:
An Evidence-Driven Rebuttal To Morgan Stanley & Goldman Sachs Bearish Thesis On Gilead Sciences (GILD)
My book:
An Evidence-Driven Rebuttal To Morgan Stanley & Goldman Sachs Bearish Thesis On Gilead Sciences (GILD)
  • Shire (SHPG) Bid Came In As Expected 0 comments
    Jul 14, 2014 4:38 AM | about stocks: ABBV, SHPG

    Abbvie (NYSE:ABBV) came in right on target, only 0.80 Pounds Off From Our 5400 Pence Target At 5320 Pence. Congrats to Shire management for a job well done maximizing shareholder value, and congrats to ABBV, this changes a lot! From 2016 and beyond, ABBV may be able to truly maximize its balance sheet and diversify away from Humira finally. More to come later.

    Disclosure: The author is long SHPG, SHPG, ABBV, NPSP.

    Stocks: ABBV, SHPG
Back To Dr. Paul Nunzio DeSantis, Pharm.D's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.